Guidepoint Qsight and Skytale Group Report 9% Surge in Medical Aesthetic Non-Surgical Revenues in First Half of 2024 Medical aesthetics non-surgical revenues rose 9% in H1 2024, driven by semaglutides, neurotoxins, and a growing consumer base, per Guidepoint & Skytale.